Morgan Stanley’s Conformis, Inc. Common Stock CFMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,086
| Closed | -$8.95K | – | 7862 |
|
|
2023
Q2 | $8.95K | Buy |
4,086
+2,640
| +183% | +$3.75K | ﹤0.01% | 6847 |
|
|
2023
Q1 | $2.33K | Sell |
1,446
-5,135
| -78% | -$11K | ﹤0.01% | 7212 |
|
|
2022
Q4 | $21.8K | Buy |
6,581
+4,773
| +264% | +$14.8K | ﹤0.01% | 6657 |
|
|
2022
Q3 | $9K | Hold |
1,808
| – | – | ﹤0.01% | 7131 |
|
|
2022
Q2 | $16K | Sell |
1,808
-204
| -10% | -$2.33K | ﹤0.01% | 7084 |
|
|
2022
Q1 | $31K | Buy |
2,012
+154
| +8% | +$2.53K | ﹤0.01% | 6952 |
|
|
2021
Q4 | $35K | Buy |
1,858
+644
| +53% | +$16.5K | ﹤0.01% | 6979 |
|
|
2021
Q3 | $40K | Buy |
1,214
+876
| +259% | +$30.9K | ﹤0.01% | 6816 |
|
|
2021
Q2 | $9K | Sell |
338
-833
| -71% | -$19.7K | ﹤0.01% | 7282 |
|
|
2021
Q1 | $29K | Buy |
1,171
+1,016
| +655% | +$27.4K | ﹤0.01% | 6590 |
|
|
2020
Q4 | $3K | Sell |
155
-50
| -24% | -$863 | ﹤0.01% | 6871 |
|
|
2020
Q3 | $4K | Sell |
205
-850
| -81% | -$16.2K | ﹤0.01% | 6495 |
|
|
2020
Q2 | $22K | Buy |
1,055
+495
| +88% | +$10.3K | ﹤0.01% | 5985 |
|
|
2020
Q1 | $9K | Sell |
560
-3,200
| -85% | -$78.2K | ﹤0.01% | 6056 |
|
|
2019
Q4 | $141K | Buy |
3,760
+2,652
| +239% | +$126K | ﹤0.01% | 5544 |
|
|
2019
Q3 | $51K | Buy |
1,108
+729
| +192% | +$43.8K | ﹤0.01% | 5716 |
|
|
2019
Q2 | $41K | Sell |
379
-424
| -53% | -$34.9K | ﹤0.01% | 5693 |
|
|
2019
Q1 | $58K | Buy |
803
+533
| +197% | +$15.2K | ﹤0.01% | 5607 |
|
|
2018
Q4 | $2K | Buy |
270
+25
| +10% | +$420 | ﹤0.01% | 6455 |
|
|
2018
Q3 | $6K | Sell |
245
-2,088
| -89% | -$56.8K | ﹤0.01% | 6421 |
|
|
2018
Q2 | $73K | Sell |
2,333
-2,690
| -54% | -$93K | ﹤0.01% | 5822 |
|
|
2018
Q1 | $182K | Sell |
5,023
-916
| -15% | -$38.4K | ﹤0.01% | 5508 |
|
|
2017
Q4 | $353K | Buy |
5,939
+800
| +16% | +$63.9K | ﹤0.01% | 5166 |
|
|
2017
Q3 | $452K | Buy |
5,139
+555
| +12% | +$55K | ﹤0.01% | 4944 |
|
|
2017
Q2 | $492K | Sell |
4,584
-1,154
| -20% | -$139K | ﹤0.01% | 4802 |
|
|
2017
Q1 | $749K | Sell |
5,738
-1,589
| -22% | -$269K | ﹤0.01% | 4587 |
|
|
2016
Q4 | $1.48M | Buy |
7,327
+5,232
| +250% | +$1.16M | ﹤0.01% | 4168 |
|
|
2016
Q3 | $520K | Buy |
2,095
+260
| +14% | +$52.2K | ﹤0.01% | 4501 |
|
|
2016
Q2 | $323K | Buy |
1,835
+18
| +1% | +$4.23K | ﹤0.01% | 4684 |
|
|
2016
Q1 | $489K | Buy |
1,817
+656
| +57% | +$174K | ﹤0.01% | 4459 |
|
|
2015
Q4 | $502K | Buy |
1,161
+377
| +48% | +$189K | ﹤0.01% | 4543 |
|
|
2015
Q3 | $355K | Buy |
+784
| New | +$395K | ﹤0.01% | 4798 |
|
Other funds holding CFMS
Morgan Stanley's CFMS Position: Q3 2023 in Review
Morgan Stanley sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2023, closing a stake of 4,086 shares — an estimated $8.95K sold.
Morgan Stanley first reported a position in CFMS in Q3 2015 and held it in 32 quarters. The position peaked at $1.48M in Q4 2016. 1 fund tracked by Wall St. Rank holds CFMS as of Q3 2023.
- Morgan Stanley reported no remaining Conformis, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Morgan Stanley sold 4,086 Conformis, Inc. Common Stock shares in Q3 2023, an estimated $8.95K.
- Morgan Stanley first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 32 quarters.
- Morgan Stanley's Conformis, Inc. Common Stock position peaked at $1.48M in Q4 2016.
- 1 fund tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2023.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.